Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

5AM Solutions and LABVANTAGE Announce Partnership

Published: Sunday, February 10, 2013
Last Updated: Sunday, February 10, 2013
Bookmark and Share
Partnership to provide consulting and implementation services

5AM announced that it is partnering with LABVANTAGE Solutions, an innovative provider of enterprise laboratory informatics software. 5AM will work closely with LABVANTAGE to provide consulting and implementation services in order to support current and future LABVANTAGE customers in government organizations, commercial organizations, and academic institutions.

The partnership will initially focus on meeting increasing customer demand for training, implementation, biobanking best practices, and data standardization. 5AM’s track record of integration and implementation expertise in the domains where biospecimens play a fundamental role combined with LABVANTAGE software will provide customers the ability to fully exercise the utility of the world’s leading LIMS software faster.

“We have admired each others’ progress for years and have discovered how we can add value together,” said Erica Marrari, Biospecimen Practice Lead at 5AM Solutions. “Doing what we each do best will allow us to serve the growing market need, delivering optimal value to customers who are at the core of translating science into medical benefit.”

“As we continue to experience significant growth in the Life Science LIMS and Biobanking space, we felt it was very important for us to expand and enhance our implementation capabilities by partnering with an organization that can offer strong domain expertise and proven best practices capabilities,” said Jerry Hacker, Sr. VP of Worldwide Sales at LABVANTAGE. “We are excited about this partnership and look forward to serving our customers in a manner that meets or exceeds their expectations.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!